Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics granted inducement equity awards to six new employees covering an aggregate of 41,600 shares of common stock. The awards consist of inducement stock options to purchase 18,000 shares and inducement restricted stock units covering 23,600 shares.
Key figures
- Rsu shares
- 23600
- New employees
- 6
- Exercise price
- 56.59
- Options shares
- 18000
- Total inducement shares
- 41600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.